The acquisition brings Halda's candidate HLD-0915, a clinical-stage treatment for prostate cancer, into J&J's oncology ...

Johnson & Johnson acquires Halda Therapeutics for $3 billion to strengthen its oncology portfolio, focusing on prostate ...

Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion cash, in a deal designed to expand the buyer’s cancer pipeline with Halda’s precision oncology candidates, led by a ...

J&J's $3.05B move for Halda adds targeted oral cancer therapies and expands its prostate cancer pipeline amid rising pharma M&A.

Akzo Nobel NV has agreed to acquire smaller rival paint maker Axalta Coating Systems Ltd in a cross-border deal creating a ...

Johnson & Johnson ( JNJ) rose 0.27% to close at $200.12 on Tuesday, marking the seventh consecutive session of gains. An analyst said the company's prospects are helped by strong Q3 results and ...

Dow Jones Top Company Headlines at 5 AM ET: Baidu Revenue Falls on Weak Advertising Demand, Posts Loss on Impairment | AkzoNobel, ... Baidu Revenue Falls on Weak Advertising Demand, Posts Loss on ...

Novo Nordisk to lower cash-pay prices for Ozempic and Wegovy to $349 a month; J&J buys Halda Therapeutics for $3.05 billion; Trump attacking health insurers underscores rising tensions around ...

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

Johnson & Johnson (JNJ) slipped 0.18% to $199.22 in afternoon trade on Tuesday, ending six-sessions of gain. Despite today's ...

A new word is making the rounds in the business press: "anti-involution." In recent years, Chinese companies have built ...

The information Variety published is categorically inaccurate,” a spokesperson for Paramount said in a statement to.